ARTICLE | Clinical News
Ibudilast regulatory update
March 11, 2013 7:00 AM UTC
MediciNova said FDA granted Fast Track designation for ibudilast to treat methamphetamine dependence. The phosphodiesterase-4 (PDE-4), leukotriene B4 receptor and nitric oxide (NO) synthase inhibit...